IRHYTHM HLDGS is a digital health care company which creates trusted solutions that detect, predict and prevent disease. IRHYTHM HLDGS, formerly known as iRhythm Technologies Inc., is based in SAN FRANCISCO.
| Revenue (Most Recent Fiscal Year) | $747.14M |
| Net Income (Most Recent Fiscal Year) | $-44.55M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 5.05 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 24.64 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -5.84% |
| Net Margin (Trailing 12 Months) | -5.96% |
| Return on Equity (Trailing 12 Months) | -28.15% |
| Return on Assets (Trailing 12 Months) | -3.35% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.63 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.48 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 4.25 |
| Inventory Turnover (Trailing 12 Months) | 11.90 |
| Book Value per Share (Most Recent Fiscal Quarter) | $4.74 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.29 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.03 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.40 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 32.32M |
| Free Float | 31.96M |
| Market Capitalization | $3.77B |
| Average Volume (Last 20 Days) | 0.56M |
| Beta (Past 60 Months) | 1.18 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.10% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |